Bilim ve teknolojideki ilerlemeler, kronik hastalıkların yönetimini ve kontrolünü kolaylaştırırken, bireylerin hastalık yönetiminde güçlenmesine olanak sağlamaktadır. Diyabetli bireylerin öz yönetimlerini artırmak ve güçlendirmek için bilişim teknolojileriyle desteklenmeleri önemlidir. Son yıllarda diyabet teknolojisi hızla gelişmiş ve yeni teknolojiler geliştirilmiştir. Bu geliştirilen teknolojiler; diyabetin etkin yönetimine, bireylerin yaşam kalitesinin artırılmasına ve hastalığın neden olduğu fiziksel, psikolojik, sosyal yüklerin azalmasına katkı sağlamıştır. Diyabetteki teknolojik ilerlemelerin temeli, sürekli deri altı insülin infüzyonu (CSII veya insülin pompası) ve sürekli glikoz izleme [continuous glucose monitoring (CGM)] sistemlerinin geliştirilmesi üzerinedir. CGM cihazları, implante edilebilir subkütan CGM sistemi, insülin pompası, insülin portu, hipoglisemi uyarı bilekliği, nazal glukagon gibi ürünler, diyabet teknolojisi içinde yer almaktadır. Bu cihazlara ek olarak, noninvaziv glikoz ölçümü sağlayabileceği düşünülen mikroinvaziv yama, hidrojel dövme, terden (gözlük ve bileklik) glikoz ölçümü, tükürükten glikoz ölçümü yapan biyosensörler, diş aksesuarları ve akıllı kontak lens ile glikoz ölçüm yöntemleri üzerine çalışmalar hâlâ devam etmektedir. Diyabet yönetiminde kullanılan ve üzerinde çalışmaların devam ettiği bu teknolojik gelişmeler, bireyin hastalığı üzerindeki kontrolünü, yaşam kalitesini ve konforunu artırmayı hedeflemektedir. Sağlık profesyonellerinin, teknolojik gelişmeler konusunda bilgi ve fikir sahibi olması, eğitim, danışmanlık rollerini yerine getirmesinde önemlidir. Ayrıca bu konudaki okumalar, çözümler için yeni fikirlere, kullanılan teknolojik ürünlerin özelliklerinin geliştirilmesine ya da farklı ürünlerin ortaya çıkarılmasına altyapı sağlayabilir.
Anahtar Kelimeler: Diyabet; diyabet yönetimi; teknoloji
Progresses in science and technology facilitate the management and control of chronic diseases, while enabling individuals to become stronger in disease management. It is important that individuals with diabetes are supported with information technologies to improve and strengthen their self-management. In recent years, diabetes technology improved rapidly, and new technologies were developed. These recently developed technologies have contributed to the effective management of diabetes, improving the quality of life of individuals and reducing physical, psychological and social burdens caused by the disease. Technological advances in diabetes arebased on the development of continuous subcutaneous insulin infusion (CSII or insulin pump) and continuous glucose monitoring (CGM) systems. Diabetes technology includes products such as CGM devices, implantable subcutaneous CGM system, insulin pump, insulin port, hypoglycemia stimulation wristband and nasal glucagon. In addition to these devices, studies are still ongoing on microinvasive patch, hydrogel tattoo, glucose measurement from sweat (glasses and wristband), biosensors measuring glucose from saliva, dental accessories and glucose measurement methods by smart contact lens, which are thought to allow for noninvasive glucose measurement. These technological advancements used in management of diabetes, which involve ongoing studies, aim to increase individuals control over the disease, their quality of life and comfort. It is important for health professionals to have knowledge and insight about technological advancements in fulfilling their training and consultancy roles. In addition, readings on this subject can provide infrastructure for new ideas for solutions, improvements of the features of the technological products used or discovery of different products.
Keywords: Diabetes; diabetes management; technology
- World Health Organization. Assessing national capacity for the prevention and control of noncommunicable diseases: report of the 2019 global survey. (Erişim Tarihi: 15.07.2020) [Link]
- Bloom DE, Chen S, McGovern ME. The economic burden of noncommunicable diseases and mental health conditions: results for Costa Rica, Jamaica, and Peru. Rev Panam Salud Publica. 2018;42:e18. [Crossref] [PubMed] [PMC]
- Taylor CB, Miller NH, Reilly KR, Greenwald G, Cunning D, Deeter A, et al. Evaluation of a nurse-care management system to improve outcomes in patients with complicated diabetes. Diabetes Care. 2003;26(4):1058-63. [Crossref] [PubMed]
- Özdemir Ü, Taşcı S. [Psychosocial problems and care in chronic diseases]. ERÜ Sağlık Bilimleri Fakültesi Dergisi. 2013;1(1):57-72. [Link]
- Yıldırım JG, Çevirgen A. [Information technologies applications in the management of chronic diseases]. CBU-SBED. 2019;6(1):65-73. [Link]
- Beard JR, Officer A, de Carvalho IA, Sadana R, Pot AM, Michel JP, et al. The World report on ageing and health: a policy framework for healthy ageing. Lancet. 2016;387(10033):2145-54. [Crossref] [PubMed] [PMC]
- Golics CJ, Basra MK, Salek MS, Finlay AY. The impact of patients' chronic disease on family quality of life: an experience from 26 specialties. Int J Gen Med. 2013;6:787-98. [Crossref] [PubMed] [PMC]
- The World Health Organisation. Global Health Observatory data. NCD Mortality and morbidity reportaccessed at (Erişim Tarihi: 28.05.2020) [Link]
- Karakoç Kumsar A, Taşkın Yılmaz F. [Overview of quality of life in chronic disease patients]. ERÜ Sağlık Bilimleri Fakültesi Dergisi. 2014;2(2): 62-70. [Link]
- Jeon YH, Essue B, Jan S, Wells R, Whitworth JA. Economic hardship associated with managing chronic illness: a qualitative inquiry. BMC Health Serv Res. 2009;9:182. [Crossref] [PubMed] [PMC]
- Morsanutto A, Berto P, Lopatriello S, Gelisio R, Voinovich D, Cippo PP, et al. Major complications have an impact on total annual medical cost of diabetes: results of a database analysis. J Diabetes Complications. 2006;20(3):163-9. [Crossref] [PubMed]
- Coşansu G. [Diabetes: a global epidemic disease]. Okmeydanı Tıp Dergisi. 2015;31:1-6. [Link]
- American Diabetes Association. 2. classification and diagnosis of diabetes: standards of medical care in diabetes-2018. Diabetes Care. 2018;41 (Suppl 1):13-27. [Crossref] [PubMed]
- Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. [Crossref] [PubMed]
- Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Pract. 1998;1(1):2-4. [PubMed]
- Yüksel M, Bektaş H. [Current approaches in the administration of chronic complications related to diabetes]. Turkiye Klinikleri J Nurs Sci. 2020;12(1):133-57. [Crossref]
- Jordan RE, Majothi S, Heneghan NR, Blissett DB, Riley RD, Sitch AJ, et al. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis. Health Technol Assess. 2015;19(36):1-516. [Crossref] [PubMed] [PMC]
- Panagioti M, Richardson G, Small N, Murray E, Rogers A, Kennedy A, et al. Self-management support interventions to reduce health care utilisation without compromising outcomes: a systematic review and meta-analysis. BMC Health Serv Res. 2014;14:356. [Crossref] [PubMed] [PMC]
- Walker RC, Tong A, Howard K, Palmer SC. Patient expectations and experiences of remote monitoring for chronic diseases: Systematic review and thematic synthesis of qualitative studies. Int J Med Inform. 2019;124:78-85. [Crossref] [PubMed]
- Peters AL, Ahmann AJ, Battelino T, Evert A, Hirsch IB, Murad MH, et al. Diabetes technology-continuous subcutaneous insulin infusion therapy and continuous glucose monitoring in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(11):3922-37. [Crossref] [PubMed]
- Heinemann L. Future of diabetes technology. J Diabetes Sci Technol. 2017;11(5):863-9. [Crossref] [PubMed] [PMC]
- T.C. Sağlık Bakanlığı. [Turkey NCD multi-stakeholder action plan 2017-2025]. Erişim Tarihi: 28.05.2020. [Link]
- Funnell MM, Anderson RM. Empowerment and self-management of diabetes. Clinical Diabetes. 2004;22(3):123-7. [Crossref]
- Umpierrez GE, Klonoff DC. Diabetes Technology update: use of ınsulin pumps and continuous glucose monitoring in the hospital. Diabetes Care. 2018;41(8):1579-89. [Crossref] [PubMed] [PMC]
- Ginsberg BH. Factors affecting blood glucose monitoring: sources of errors in measurement. J Diabetes Sci Technol. 2009;3(4):903-13. [Crossref] [PubMed] [PMC]
- Lansang MC, Modic MB, Sauvey R, Lock P, Ross D, Combs P, et al. Approach to the adult hospitalized patient on an insulin pump. J Hosp Med. 2013;8(12):721-7. [Crossref] [PubMed]
- Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetes Care. 2015;38(4):716-22. [Crossref] [PubMed]
- Forlenza GP, Buckingham B, Maahs DM. Progress in diabetes technology: developments in insulin pumps, continuous glucose monitors, and progress towards the artificial pancreas. J Pediatr. 2016;169:13-20. [Crossref] [PubMed] [PMC]
- Ajjan RA. How can we realize the clinical benefits of continuous glucose monitoring? Diabetes Technol Ther. 2017;19(S2):S27-S36. [Crossref] [PubMed] [PMC]
- Klonoff DC, Ahn D, Drincic A. Continuous glucose monitoring: A review of the technology and clinical use. Diabetes Res Clin Pract. 2017;133:178-92. [Crossref] [PubMed]
- Vashist SK. Continuous glucose monitoring systems: a review. Diagnostics (Basel). 2013;3(4):385-412. [Crossref] [PubMed] [PMC]
- Hirsch IB, Armstrong D, Bergenstal RM, Buckingham B, Childs BP, Clarke WL, et al. Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). Diabetes Technol Ther. 2008;10(4):232-44; quiz 245-6. [Crossref] [PubMed]
- Polonsky WH, Hessler D. What are the quality of life-related benefits and losses associated with real-time continuous glucose monitoring? A survey of current users. Diabetes Technol Ther. 2013;15(4):295-301. [Crossref] [PubMed]
- Tanenbaum ML, Hanes SJ, Miller KM, Naranjo D, Bensen R, Hood KK. Diabetes device use in adults with type 1 diabetes: barriers to uptake and potential intervention targets. Diabetes Care. 2017;40(2):181-7. [Crossref] [PubMed] [PMC]
- Tansey M, Laffel L, Cheng J, Beck R, Coffey J, Huang E, et al; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes. Diabet Med. 2011;28(9):1118-22. [Crossref] [PubMed]
- Cemeroglu AP, Stone R, Kleis L, Racine MS, Postellon DC, Wood MA. Use of a real-time continuous glucose monitoring system in children and young adults on insulin pump therapy: patients' and caregivers' perception of benefit. Pediatr Diabetes. 2010;11(3):182-7. [Crossref] [PubMed]
- Christiansen MP, Klaff LJ, Bailey TS, Brazg R, Carlson G, Tweden KS. A prospective multicenter evaluation of the accuracy and safety of an implanted continuous glucose sensor: The PRECISION study. Diabetes Technology & Therapeutics. 2019;21(5):231-7. [Crossref] [PubMed] [PMC]
- Christiansen MP, Klaff LJ, Brazg R, Chang AR, Levy CJ, Lam D, et al. A prospective multicenter evaluation of the accuracy of a novel ımplanted continuous glucose sensor: PRECISE II. Diabetes Technol Ther. 2018;20(3):197-206. [Crossref] [PubMed] [PMC]
- Dehennis A, Mortellaro MA, Ioacara S. Multisite study of an ımplanted continuous glucose sensor over 90 days in patients with diabetes Mellitus. J Diabetes Sci Technol. 2015;9(5):951-6. [Crossref] [PubMed] [PMC]
- Boland EA, Grey M, Oesterle A, Fredrickson L, Tamborlane WV. Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care. 1999;22(11):1779-84. [Crossref] [PubMed]
- Berthe E, Lireux B, Coffin C, Goulet-Salmon B, Houlbert D, Boutreux S, et al. Effectiveness of intensive insulin therapy by multiple daily injections and continuous subcutaneous infusion: a comparison study in type 2 diabetes with conventional insulin regimen failure. Horm Metab Res. 2007;39(3):224-9. [Crossref] [PubMed]
- Ghazanfar H, Rizvi SW, Khurram A, Orooj F, Qaiser I. Impact of insulin pump on quality of life of diabetic patients. Indian J Endocrinol Metab. 2016;20(4):506-11. [Crossref] [PubMed] [PMC]
- Didangelos T, Iliadis F. Insulin pump therapy in adults. Diabetes Res Clin Pract. 2011;93 Suppl 1:S109-13. [Crossref] [PubMed]
- Aleppo G, Webb KM. Integrated insulin pump and continuous glucose monitoring technology in diabetes care today: a perspective of real-life experience with the MINIMED? 670g hybrid closed-loop system. Endocr Pract. 2018;24(7):684-92. [Crossref] [PubMed]
- Faulds ER, Zappe J, Dungan KM. Real-world implications of hybrid close loop (hcl) insulin delivery system. Endocr Pract. 2019;25(5):477-84. [Crossref] [PubMed] [PMC]
- Knebel T, Neumiller JJ. Medtronic MiniMed 670G hybrid closed-loop system. Clin Diabetes. 2019;37(1):94-5. [Crossref] [PubMed] [PMC]
- Garg SK, Weinzimer SA, Tamborlane WV, Buckingham BA, Bode BW, Bailey TS, et al. Glucose outcomes with the in-home use of a hybrid closed-loop ınsulin delivery system in adolescents and adults with Type 1 diabetes. Diabetes Technol Ther. 2017;19(3):155-63. [Crossref] [PubMed] [PMC]
- Medtronic [Internet]. © 2020 Medtronic [cited 29.5.2020]. İ-Port Advance. Available from: [Link]
- Hypoband [Internet]. © 2020, Hypoband [cited 29.5.2020]. Why Hypoband. Available from: (Erişim:29.05.2020) [Link]
- Pöhlmann J, Mitchell BD, Bajpai S, Osumili B, Valentine WJ. Nasal glucagon versus injectable glucagon for severe hypoglycemia: a cost-offset and budget impact analysis. J Diabetes Sci Technol. 2019;13(5):910-8. [Crossref] [PubMed] [PMC]
- Kedia N. Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach. Diabetes Metab Syndr Obes. 2011;4:337-46. [Crossref] [PubMed]
- Bandodkar AJ, Jia W, Yardımcı C, Wang X, Ramirez J, Wang J. Tattoo-based noninvasive glucose monitoring: a proof-of-concept study. Anal Chem. 2015;87(1):394-8. [Crossref] [PubMed]
- Bruen D, Delaney C, Florea L, Diamond D. Glucose sensing for diabetes monitoring: recent developments. Sensors (Basel). 2017;17(8):1866. [Crossref] [PubMed] [PMC]
- Yu J, Zhang Y, Ye Y, DiSanto R, Sun W, Ranson D, et al. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery. Proc Natl Acad Sci USA. 2015;112(27):8260-5. [Crossref] [PubMed] [PMC]
- Veiseh O, Langer R. Diabetes: A smart insulin patch. Nature. 2015;524(7563):39-40. [Crossref] [PubMed]
- Patients Pending Limited. Timesulin. Available from: (Erişim Tarihi: 15.07.2020) [Link]
- Novolog [Internet]. © 2020 Novo Nordisk. [cited 15.07.2020]. NovoLog® has insulin pens designed to meet your patients' needs. Available from: [Link]
- Companion Medical [Internet]. © 2021 Companion Medical. [cited 15.7.2020]. InPen. Available from: [Link]
- Zhai YK, Zhu WJ, Cai YL, Sun DX, Zhao J. Clinical-and cost-effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis. Medicine (Baltimore). 2014;93(28):e312. [Crossref] [PubMed] [PMC]
- Craig J, Patterson V. Introduction to the practice of telemedicine. J Telemed Telecare. 2005;11(1):3-9. [Crossref] [PubMed]
- Klonoff DC. Telemedicine for diabetes: current and future trends. j diabetes sci technol. 2015;10(1):3-5. [Crossref] [PubMed] [PMC]
- Liang X, Wang Q, Yang X, Cao J, Chen J, Mo X, et al. Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diabet Med. 2011;28(4):455-63. [Crossref] [PubMed]
- Voluntis [Internet]. ©Voluntis 2020. [cited: 15.7.2020]. Our digital therapeutics: diabetes. Insulia. Available from: [Link]
- Debong F, Mayer H, Kober J. Real-World Assessments of mySugr Mobile Health App. Diabetes Technol Ther. 2019;21(S2):S235-S240. [Crossref] [PubMed]
- mySugr GmbH. mySugr. Available from: (Erişim Tarihi: 15.7.2020) [Link]
.: Process List